Powered by Protein Production Technology InternationalAs precision fermentation moves from the laboratory into commercial manufacturing, the ability to measure, interpret, and control a process becomes increasingly important. Conditions that are relatively easy to monitor in a small bioreactor can become far more complex at industrial scale, where variability, changing cell behavior, and process limitations can affect yield, consistency, and cost.In this episode of the Protein Production

Episode SummaryThis month on the Deep-Sea Podcast, we speak with Anne Helene Tandberg, a researcher from the University Museum of Bergen who specializes in amphipods and curated the deep-sea exhibit at the University Museum of Bergen, Norway. Check out our lovely new website where you can find more detailed notes, images and links to the wider reading. In this episode… Welcome back to the Deep-Sea Podcast, your punk take on all things deep sea! Alan is living day 56 on a boat, and feeling

A special episode hosted by Swiss Medtech, with Barbara Mettler asking the questions. Prof. Dr. Martin Scheringer from ETH Zurich, toxicologist Arne Jaksch and Lucas Pianegonda work through what medtech companies should actually do about PFAS this year. In this episode: - Where PFAS sit beyond the product: process water, piping, cooling and cutting fluids, packaging, processing aids - Why your supply chain will be interrupted before any regulatory grace period ends, and what to do about i...

Bu bölümde, Birleşik Krallık MHRA'nın hasta kaldırma cihazları ve sapanları için yayınladığı Ulusal Hasta Güvenliği Uyarısı'nı (NatPSA/2026/005/MHRA) ele alıyoruz. Ölüm ve ciddi yaralanma risklerini azaltmak amacıyla hem sağlık hizmeti sağlayıcıları hem de üreticiler için zorunlu kılınan eylemleri ve 29 Eylül 2026 tarihli son uyum tarihini ayrıntılı olarak inceliyoruz. Üreticilerin teknik dosyalarını, kullanım talimatlarını ve pazar sonrası gözetim stratejilerini bu yeni gerekliliklere göre nasıl

I det här avsnittet diskuterar vi den brittiska MHRA:s nationella patientsäkerhetsvarning (NatPSA/2026/005/MHRA) gällande patientlyftar och selar. Vi går igenom de specifika riskerna för dödsfall och allvarliga skador som MHRA har identifierat, inklusive mekaniska fel och användarfel. Vi beskriver de obligatoriska åtgärder som vårdgivare och tillverkare måste vidta före tidsfristen den 29 september 2026 för att säkerställa patientsäkerheten och uppfylla kraven. Nyckelfrågor: - Vilka specifika

Neste episódio, analisamos em profundidade o Alerta Nacional de Segurança do Paciente (NatPSA/2026/005/MHRA) da MHRA do Reino Unido, que aborda os riscos de morte e lesões graves por quedas de guinchos e arneses para pacientes. Discutimos as causas principais, incluindo falhas mecânicas e erros do utilizador, e detalhamos as ações obrigatórias para fabricantes e prestadores de cuidados de saúde, com um prazo final em 29 de setembro de 2026. Oferecemos passos práticos que as equipes regulatórias e de

Cet épisode analyse en profondeur l'Alerte Nationale de Sécurité des Patients (NatPSA/2026/005/MHRA) émise par la MHRA du Royaume-Uni le 29 septembre 2026, concernant les lève-personnes et les élingues. Nous détaillons les risques de chutes mortelles ou graves dus à des défaillances mécaniques et à des erreurs d'utilisation, et nous décrivons les actions obligatoires pour les prestataires de soins de santé et les fabricants. Découvrez les étapes pratiques que les équipes réglementaires et qualité

यह एपिसोड यूके MHRA के राष्ट्रीय रोगी सुरक्षा अलर्ट (NatPSA/2026/005/MHRA) पर केंद्रित है, जो रोगी होइस्ट (patient hoists) और स्लिंग (slings) से संबंधित है। हम MHRA द्वारा पहचानी गई गिरने से होने वाली मौतों और गंभीर चोटों के विशिष्ट जोखिमों पर चर्चा करते हैं, जिनमें यांत्रिक विफलताएं और उपयोगकर्ता त्रुटियां शामिल हैं। हम स्वास्थ्य सेवा प्रदाताओं और निर्माताओं के लिए 29 सितंबर, 2026 की समय सीमा तक इन जोखिमों को कम करने के लिए आवश्यक कार्रवाइयों का विवरण देते हैं। Key Questions: - यूके MHRA की रोगी

Cơ quan Quản lý Thuốc và Sản phẩm Chăm sóc Sức khỏe của Vương quốc Anh (MHRA) đã ban hành Cảnh báo An toàn Bệnh nhân Quốc gia (NatPSA/2026/005/MHRA) quan trọng, giải quyết các rủi ro tử vong và thương tích nghiêm trọng do ngã từ thiết bị nâng bệnh nhân và dây treo. Tập này phân tích các hành động bắt buộc đối với các nhà cung cấp dịch vụ chăm sóc sức khỏe và nhà sản xuất thiết bị y tế, bao gồm các yêu cầu cập nhật tài liệu, tăng cường đào tạo và cải thiện các quy trình an toàn. Chúng tôi thảo luận

В этом выпуске мы подробно рассматриваем Национальное предупреждение о безопасности пациентов (NatPSA/2026/005/MHRA), выпущенное Управлением по регулированию лекарственных средств и изделий медицинского назначения Великобритании (MHRA). Мы обсуждаем серьезные риски падений, связанные с подъемниками для пациентов и стропами, включая механические неисправности и ошибки пользователей. Эпизод освещает обязательные действия, которые производители и поставщики медицинских услуг должны предпринять до 29

Episode ini membahas secara mendalam Peringatan Keselamatan Pasien Nasional (NatPSA/2026/005/MHRA) dari MHRA Inggris mengenai risiko serius yang terkait dengan alat pengangkat pasien (patient hoists) dan gendongan (slings). Kami menguraikan tindakan yang diperlukan bagi produsen dan penyedia layanan kesehatan untuk mengurangi risiko jatuh yang fatal sebelum batas waktu 29 September 2026. Pelajari langkah-langkah praktis yang harus diambil oleh tim regulasi dan kualitas Anda, termasuk meninjau

Kan ve gül, gülle diken, aşkım ve sen

Delayed Friday edition, recorded October 2. Lilly's Jaypirca (pirtobrutinib) gains first-line approval for adults with CLL/SLL without a known 17p deletion—but how does a trial against older chemotherapy guide today's treatment choice? Novartis agrees to $575 million upfront for Abogen's early-stage RNA medicine ABO2203, with closing still pending and autoimmune benefit unproven. Also: Pfizer's Litfulo (ritlecitinib) advances toward vitiligo filings; Biogen reports longer-term

Get in touch to share sheeping stories or questions anytime! We love hearing from our listeners and in this episode we answer some interesting questions from listeners on routine hoof care for sheep and how and when to castrate lambs. Andrew recently attended the Irish Lanark society sale in Roscommon and his buying strategy paid off big time! Thanks for listening! Thank you for supporting our pod! Sign up via our sheep supporters tab ! https://www.buzzsprout.com/954910/supporter...

Ти можеш змінити віру, партію чи ставлення до війни. А чи можеш зробити так, щоб партнер дізнався про це останнім?Дві позиції, жодної згоди. Перша: мовчання і є порушенням договору, якого ніхто не озвучував. Друга: мовчання буває межею, а не порушенням довіри.Чесно про докази: жодне з використаних досліджень не міряє зміну світогляду всередині шлюбу. Ми спираємось на найближче: як релігійні й політичні розбіжності між подружжям та приховування в парах пов'язані зі стабільністю й якістю

This digest covers key developments from Shionogi, Alector and Eli Lilly, including corporate acquisitions, a Parkinson’s disease licensing deal and a first-line label expansion, alongside broader coverage across the sector.This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

In this classic episode of Stuff to Blow Your Mind, Robert and Joe discuss the idea of Egyptian tomb curses, how they actually factored into ancient Egyptian practices and where the myth of the Pharaoh's curse meets reality. (originally published 9/30/2025)See omnystudio.com/listener for privacy information.

Un logiciel qui repère le stade B2 de la maladie valvulaire mitrale sans échographe, une sonde thermique censée trier lipomes et mastocytomes, des assistants grand public qui notent des radios de veaux face à de jeunes vétérinaires : Mathieu Lamant et Julie passent ces promesses au crible, chiffres et limites compris. Ils s'arrêtent ensuite sur la flagornerie numérique, cette tendance des IA à valider l'hypothèse de leur utilisateur, puis sur deux évolutions de VetInterniste qui confrontent l'image

In questo episodio, analizziamo l'avviso di sicurezza dei dispositivi (DSI/2026/012) emesso dalla MHRA del Regno Unito il 29 settembre 2026, riguardante i sistemi di cardiotocografia (CTG) wireless. Approfondiamo i rischi specifici di crossover del segnale e di interruzione del segnale identificati dalla MHRA e discutiamo le implicazioni critiche per la conformità post-commercializzazione e la gestione del rischio per i produttori di dispositivi medici abilitati alla radiofrequenza.Key

Planetterrian Daily 🌍 Planetterrian Daily - Science, Longevity & Health Discoveries A single mitochondrial protein links the circadian clock directly to brown fat metabolism in new Science findings. Top 15 Science & Health Discoveries Skin functions as dynamic organ beyond appearance — Yahoo Creators Skin performs immune surveillance, temperature regulation, vitamin D synthesis, and microbiome support. ... Sources: creators.yahoo.com · bioengineer.org · science.org · nytimes.com ·